Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data
10.1186/s12933-021-01345-z
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
BioMed Central Ltd
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/233558 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-233558 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-2335582023-08-27T22:31:36Z Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data Khunti, Kamlesh Kosiborod, Mikhail Kim, Dae Jung Kohsaka, Shun Lam, Carolyn S. P. Goh, Su-Yen Chiang, Chern-En Shaw, Jonathan E. Cavender, Matthew A. Tangri, Navdeep Franch-Nadal, Josep Holl, Reinhard W. Jørgensen, Marit E. Norhammar, Anna Eriksson, Johan G. Zaccardi, Francesco Karasik, Avraham Magliano, Dianna J. Thuresson, Marcus Chen, Hungta Wittbrodt, Eric Bodegård, Johan Surmont, Filip Fenici, Peter Wilding, John P. Birkeland, Kåre Carstensen, Bendix Jørgensen, Marit E. Lam, Carolyn S. P. Kendrick, Rachel Belli, Wesley Wittbrodt, Eric Franch-Nadal, Josep Noguchi, Yusuke Tangri, Navdeep Kohsaka, Shun Kim, Dae Jung Shaw, Jonathan E. Andersson-Sundell, Karolina Goh, Su-Yen Chiang, Chern-En Eriksson, Johan G. Zaccardi, Francesco Chen, Hungta Kadir, Hanis Abdul Ha, Kyoung Hwa Lee, Jinhee Chodick, Gabriel Cohen, Cheli Melzer Whitlock, Reid Soriano, Lucia Cea Cantero, Oscar Fernándex Menzin, Jordan A. Guthrie, Matthew Ilomaki, Jennie Hoti, Fabian Christopher, Solomon Vehkala, Minna DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL) OBSTETRICS & GYNAECOLOGY DUKE-NUS MEDICAL SCHOOL Cardiovascular outcomes Heart failure Sodium–glucose cotransporter-2 inhibitors Type 2 diabetes 10.1186/s12933-021-01345-z Cardiovascular Diabetology 20 1 159 2022-10-26T09:02:26Z 2022-10-26T09:02:26Z 2021-07-31 Article Khunti, Kamlesh, Kosiborod, Mikhail, Kim, Dae Jung, Kohsaka, Shun, Lam, Carolyn S. P., Goh, Su-Yen, Chiang, Chern-En, Shaw, Jonathan E., Cavender, Matthew A., Tangri, Navdeep, Franch-Nadal, Josep, Holl, Reinhard W., Jørgensen, Marit E., Norhammar, Anna, Eriksson, Johan G., Zaccardi, Francesco, Karasik, Avraham, Magliano, Dianna J., Thuresson, Marcus, Chen, Hungta, Wittbrodt, Eric, Bodegård, Johan, Surmont, Filip, Fenici, Peter, Wilding, John P., Birkeland, Kåre, Carstensen, Bendix, Jørgensen, Marit E., Lam, Carolyn S. P., Kendrick, Rachel, Belli, Wesley, Wittbrodt, Eric, Franch-Nadal, Josep, Noguchi, Yusuke, Tangri, Navdeep, Kohsaka, Shun, Kim, Dae Jung, Shaw, Jonathan E., Andersson-Sundell, Karolina, Goh, Su-Yen, Chiang, Chern-En, Eriksson, Johan G., Zaccardi, Francesco, Chen, Hungta, Kadir, Hanis Abdul, Ha, Kyoung Hwa, Lee, Jinhee, Chodick, Gabriel, Cohen, Cheli Melzer, Whitlock, Reid, Soriano, Lucia Cea, Cantero, Oscar Fernándex, Menzin, Jordan A., Guthrie, Matthew, Ilomaki, Jennie, Hoti, Fabian, Christopher, Solomon, Vehkala, Minna (2021-07-31). Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data. Cardiovascular Diabetology 20 (1) : 159. ScholarBank@NUS Repository. https://doi.org/10.1186/s12933-021-01345-z 1475-2840 https://scholarbank.nus.edu.sg/handle/10635/233558 Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/ BioMed Central Ltd Scopus OA2021 |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
topic |
Cardiovascular outcomes Heart failure Sodium–glucose cotransporter-2 inhibitors Type 2 diabetes |
spellingShingle |
Cardiovascular outcomes Heart failure Sodium–glucose cotransporter-2 inhibitors Type 2 diabetes Khunti, Kamlesh Kosiborod, Mikhail Kim, Dae Jung Kohsaka, Shun Lam, Carolyn S. P. Goh, Su-Yen Chiang, Chern-En Shaw, Jonathan E. Cavender, Matthew A. Tangri, Navdeep Franch-Nadal, Josep Holl, Reinhard W. Jørgensen, Marit E. Norhammar, Anna Eriksson, Johan G. Zaccardi, Francesco Karasik, Avraham Magliano, Dianna J. Thuresson, Marcus Chen, Hungta Wittbrodt, Eric Bodegård, Johan Surmont, Filip Fenici, Peter Wilding, John P. Birkeland, Kåre Carstensen, Bendix Jørgensen, Marit E. Lam, Carolyn S. P. Kendrick, Rachel Belli, Wesley Wittbrodt, Eric Franch-Nadal, Josep Noguchi, Yusuke Tangri, Navdeep Kohsaka, Shun Kim, Dae Jung Shaw, Jonathan E. Andersson-Sundell, Karolina Goh, Su-Yen Chiang, Chern-En Eriksson, Johan G. Zaccardi, Francesco Chen, Hungta Kadir, Hanis Abdul Ha, Kyoung Hwa Lee, Jinhee Chodick, Gabriel Cohen, Cheli Melzer Whitlock, Reid Soriano, Lucia Cea Cantero, Oscar Fernándex Menzin, Jordan A. Guthrie, Matthew Ilomaki, Jennie Hoti, Fabian Christopher, Solomon Vehkala, Minna Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data |
description |
10.1186/s12933-021-01345-z |
author2 |
DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL) |
author_facet |
DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL) Khunti, Kamlesh Kosiborod, Mikhail Kim, Dae Jung Kohsaka, Shun Lam, Carolyn S. P. Goh, Su-Yen Chiang, Chern-En Shaw, Jonathan E. Cavender, Matthew A. Tangri, Navdeep Franch-Nadal, Josep Holl, Reinhard W. Jørgensen, Marit E. Norhammar, Anna Eriksson, Johan G. Zaccardi, Francesco Karasik, Avraham Magliano, Dianna J. Thuresson, Marcus Chen, Hungta Wittbrodt, Eric Bodegård, Johan Surmont, Filip Fenici, Peter Wilding, John P. Birkeland, Kåre Carstensen, Bendix Jørgensen, Marit E. Lam, Carolyn S. P. Kendrick, Rachel Belli, Wesley Wittbrodt, Eric Franch-Nadal, Josep Noguchi, Yusuke Tangri, Navdeep Kohsaka, Shun Kim, Dae Jung Shaw, Jonathan E. Andersson-Sundell, Karolina Goh, Su-Yen Chiang, Chern-En Eriksson, Johan G. Zaccardi, Francesco Chen, Hungta Kadir, Hanis Abdul Ha, Kyoung Hwa Lee, Jinhee Chodick, Gabriel Cohen, Cheli Melzer Whitlock, Reid Soriano, Lucia Cea Cantero, Oscar Fernándex Menzin, Jordan A. Guthrie, Matthew Ilomaki, Jennie Hoti, Fabian Christopher, Solomon Vehkala, Minna |
format |
Article |
author |
Khunti, Kamlesh Kosiborod, Mikhail Kim, Dae Jung Kohsaka, Shun Lam, Carolyn S. P. Goh, Su-Yen Chiang, Chern-En Shaw, Jonathan E. Cavender, Matthew A. Tangri, Navdeep Franch-Nadal, Josep Holl, Reinhard W. Jørgensen, Marit E. Norhammar, Anna Eriksson, Johan G. Zaccardi, Francesco Karasik, Avraham Magliano, Dianna J. Thuresson, Marcus Chen, Hungta Wittbrodt, Eric Bodegård, Johan Surmont, Filip Fenici, Peter Wilding, John P. Birkeland, Kåre Carstensen, Bendix Jørgensen, Marit E. Lam, Carolyn S. P. Kendrick, Rachel Belli, Wesley Wittbrodt, Eric Franch-Nadal, Josep Noguchi, Yusuke Tangri, Navdeep Kohsaka, Shun Kim, Dae Jung Shaw, Jonathan E. Andersson-Sundell, Karolina Goh, Su-Yen Chiang, Chern-En Eriksson, Johan G. Zaccardi, Francesco Chen, Hungta Kadir, Hanis Abdul Ha, Kyoung Hwa Lee, Jinhee Chodick, Gabriel Cohen, Cheli Melzer Whitlock, Reid Soriano, Lucia Cea Cantero, Oscar Fernándex Menzin, Jordan A. Guthrie, Matthew Ilomaki, Jennie Hoti, Fabian Christopher, Solomon Vehkala, Minna |
author_sort |
Khunti, Kamlesh |
title |
Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data |
title_short |
Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data |
title_full |
Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data |
title_fullStr |
Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data |
title_full_unstemmed |
Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data |
title_sort |
cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of cvd-real data |
publisher |
BioMed Central Ltd |
publishDate |
2022 |
url |
https://scholarbank.nus.edu.sg/handle/10635/233558 |
_version_ |
1779155294192926720 |